News

This global biochemical profiling technology, called mVision, will provide analysis of samples from bioreactors. Using mVision, Pfizer will be able to rapidly understand cellular metabolism in the biopharmaceutical

The US marketing clearance has been received for the Inion S-1 anterior cervical fusion system, the Inion S-1 double-level plate and the Inion S-2 anterior thoraco-lumbar fusion system.

The closing of this offering is expected to take place on July 25, 2008. Proceeds from the transaction will be used in the further development of Optimer’s ongoing

INOflo is said to be the first pharmaceutical gas approved in Japan and has been designated as an orphan drug by Japan’s Ministry of Health, Labor and Welfare,

The study is designed to assess the hormonal efficacy, pharmacokinetic and safety of its formulation of goserelin (Zoladex) in prostate cancer patients. The goserelin formulation is manufactured by

The design of the Phase IIb trial of TC-5214 includes two phases. In the first phase, subjects diagnosed with major depressive disorder (MDD) will receive citalopram hydrobromide, a

The original agreement signed between Cura and GeoPharma provided Cura the exclusive US distribution rights of GeoPharma’s patented oral Mucotrol wafer, which had received the FDA approval as

Prior to joining Bristol-Myers Squibb, Mr Roach was vice president of global customer strategy and process management at Bausch & Lomb where he also led the company’s global

Mr Donahue succeeds Palladian founder Kevin Cichocki, who was elected vice chairman of the board and will continue to serve as chief clinical officer. Paul Candino was also